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The packaging signal () of human immunodeficiency virus type 2 (HIV-2) is present in the 5ⴕ noncoding
region of RNA and contains a 10-nucleotide palindrome (pal; 5ⴕ-392-GGAGUGCUCC) located upstream of the
dimerization signal stem-loop 1 (SL1). pal has been shown to be functionally important in vitro and in vivo.
We previously showed that the 3ⴕ side of pal (GCUCC-3ⴕ) is involved in base-pairing interactions with a
sequence downstream of SL1 to make an extended SL1, which is important for replication in vivo and the
regulation of dimerization in vitro. However, the role of the 5ⴕ side of pal (5ⴕ-GGAGU) was less clear. Here, we
characterized this role using an in vivo SELEX approach. We produced a population of HIV-2 DNA genomes
with random sequences within the 5ⴕ side of pal and transfected these into COS-7 cells. Viruses from COS-7
cells were used to infect C8166 permissive cells. After several weeks of serial passage in C8166 cells, surviving
viruses were sequenced. On the 5ⴕ side of pal there was a striking convergence toward a GGRGN consensus
sequence. Individual clones with consensus and nonconsensus sequences were tested in infectivity and packaging assays. Analysis of individuals that diverged from the consensus sequence showed normal viral RNA and
protein synthesis but had replication defects and impaired RNA packaging. These findings clearly indicate that
the GGRG motif is essential for viral replication and genomic RNA packaging.
SD (24) or even outside the 5⬘ leader region (7). Thus, the full
HIV-1 packaging signal is a complex, compound structure.
The HIV-2 packaging signal has been less extensively studied and conclusions about the exact location of the ⌿ core have
been more controversial (20, 21, 35, 41). Several studies demonstrated the importance of sequences located downstream of
SD (20, 41). However, other studies showed that deletion of a
28-nucleotide (nt) sequence located upstream of SD caused a
severe packaging defect for HIV-2 genomic RNA packaging,
whereas mutation of sequences downstream of SD had mild
effects on packaging (21, 35). The unusual localization of the
HIV-2 ⌿ core upstream of SD suggested that, unlike HIV-1,
the strongest HIV-2 packaging signal is present in both unspliced and spliced viral RNAs (35). In addition, a 10-nt palindrome sequence (pal; 5⬘-392GGAGUGCUCC401) was described within the 28-nt ⌿ core sequence, just upstream of the
SL1 dimerization signal (see Fig. 1B) (25). Mutations of the pal
element revealed its involvement in RNA dimerization both in
vitro and in vivo (3, 25, 26, 30).
Since the Pal motif is present in the HIV-2 packaging signal
and can interfere with HIV-2 leader RNA dimerization in
vitro, its role during viral replication was investigated. Deletion
and substitution studies indicated that pal is required for efficient genome packaging and viral replication (26). Reversion
analysis of pal mutant viruses in long-term culture suggested
that the 3⬘ side of pal (GCUCC-3⬘) interacts with a downstream sequence and forms an extension of SL1 called stem B
that is required for viral replication and genomic encapsidation
(26). In parallel, an in vitro SELEX study found the 3⬘ side of
pal to be involved in the stem B structure that regulates SL1mediated HIV-2 RNA dimerization in vitro (3). Finally, mutations in the pal/SL1 region showed pal to be the most
important determinant for genomic RNA packaging and
dimerization (30).

The 5⬘ leader RNA of retroviruses is involved in the regulation
of many essential steps of the retroviral replication cycle. These
steps include transcription, splicing, translation, genomic RNA
dimerization, packaging, and reverse transcription (RT) (1, 8, 12,
27, 34–36, 38, 40). RNA packaging is a critical step during which
two molecules of full-length genomic RNA are encapsidated into
the budding virion in the form of a dimer (for a review, see
reference 42). Furthermore, packaging is a highly selective and
specific process in which unspliced genomic RNA is preferentially
incorporated in viral particles over a vast excess of cellular
mRNAs and spliced viral RNAs (31, 32). This selectivity occurs
through the interaction between trans-acting Gag polyprotein and
cis-acting elements in the genomic RNA. The cis elements are
known as packaging signals (psi or ⌿) and have been mapped in
the 5⬘ leader region of unspliced genomic RNA in many
retroviruses (22, 31, 42).
The packaging signal of human immunodeficiency virus type
1 (HIV-1) has been extensively studied. Deletion analyses have
found that the most important packaging signal (⌿ core) of
HIV-1 genomic RNA lies between the major splice donor site
(SD) and the gag initiation codon in the leader region (2, 10,
29). In vitro studies have suggested that the HIV-1 packaging
signal is composed of at least four stem-loops located both
upstream and downstream of SD (6, 11). Although the HIV-1
⌿ core is located downstream of SD in the leader region, other
packaging signals have been characterized either upstream of
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These studies have clearly suggested a structural and functional role for the 3⬘ side of pal in vitro and in vivo. To
understand the role of the 5⬘ side of pal, we used an in vivo
randomization and selection methodology similar to one first
used by Berkhout and Klaver (4) to study the role of the bulge
and loop of the TAR element during viral replication in eukaryotic cells. Using this technique, we selected for replicationcompetent viruses from a population of viruses that were randomized in pal. We constructed a library of full-length HIV-2
proviral DNA genomes with random sequences in the 5⬘ side
of pal and selected viable viruses after transfection and subsequent infection of permissive cells. Our sequencing data
showed that 5⬘ pal nucleotides of the selected viable (“winner”) viruses converged to the consensus sequence 5⬘GGRGN. Analysis of individual clones that diverged from this
sequence showed replication defects and impaired RNA packaging, whereas sequences of the type 5⬘-GGRGN restored
these features. These data strongly support the hypothesis that
pal is a critical packaging signal during the HIV-2 replication
cycle.
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TABLE 1. Oligonucleotides used in this study
Oligonucleotide

Sequence (5⬘–3⬘)

M13 forward (⫺41)................CGC CAG GGT TTT CCC AGT CAC
GAC
asXhoI-AleI ............................AAC TCG AGC ACC GTC GTG
GTT TGT TCC TG
sPal-random-5.........................GGG CGG CAG GAA CAA ACC
ACG ACN NNN NGC TCC TAG
AAA GGC GCG GGC CGA GG
asROD2050.............................GGT GTC TCC CCC TGC TC
sBamT7R.................................TAG GAT CCT AAT ACG ACT CAC
TAT AGG TCG CTC TGC GGA
GAG
asEco561..................................AAG AAT TCA GTT TCT CGC GCC
CAT CTC CC
sPal-SM2 .................................GG CGG CAG GAA CAA ACC ACG
ACC CTC TGC TCC TAG AAA
GGC GCG G
sPal-TTB-16 ............................GGG CGG CAG GAA CAA ACC
ACG ACA CCT GGC TCC TAG
AAA GGC GCG G
sPal-random-2.........................GGG CGG CAG GAA CAA ACC
ACG ACG GNG NGC TCC TAG
AAA GGC GCG G

MATERIALS AND METHODS
Construction of plasmids for generation of randomized proviral DNA libraries. To rule out the chance of contamination by wild-type proviral DNA plasmid
in the pal-randomized libraries, we used a parent plasmid called pSCR2, which
harbors deleterious mutations in the pal sequence to construct our random
library. pSCR2 was derived from modified pROD10 (a full-length plasmid containing infectious HIV-2 DNA sequence) and remained noninfectious even after
several months in culture (26).
To create a vector for generating the randomized libraries, a derivative of
pSCR2 plasmid called pSCR2AleI⌬(396-2030) was constructed, in which a fragment encompassing nt 396 to 2030 of the viral genome, including part of the
noncoding region, and most of the Gag coding region up to the XhoI site was
deleted, and a nucleotide was substituted (A394T) to introduce a unique AleI
restriction site. All nucleotide numbering in the present study is referenced to the
RNA sequence of HIV-2 (ROD isolate, GenBank no. M15390). The mutated
vector sequence is as follows: 5⬘-380ACAAACCACGACGGtG395//2031CTCGA
G-3⬘, where AleI and XhoI sites are underlined and the lowercase “t” indicates
the changed nucleotide.
pSCR2AleI⌬(396-2030) was constructed as follows. A fragment containing the
long terminal repeat (LTR) and the sequence up to nt 395 with the A394T
substitution, along with the 6-nt subsequent sequence of the XhoI site, was
amplified, using a sense primer [M13 forward (⫺41) binding upstream of a
unique AatII site; Table 1] and an antisense primer (asXhoI-AleI, containing the
XhoI and AleI sites; Table 1). The amplified product was digested with AatII/
XhoI and ligated into the pSCR2 plasmid vector missing the original AatII-XhoI
fragment. The ligated product was transformed in Escherichia coli DH5␣ cells,
and ampicillin-resistant colonies were selected, followed by plasmid DNA purification.
Generation of pal-randomized proviral DNA library. To generate the proviral
DNA library that is randomized at the 5⬘ side of pal (5-nt RND pal), we used the
In-Fusion (Clontech) in vitro DNA recombination protocol, which obviates the
need of a DNA ligase step and combines the insert and vector due to the homologous regions at both the 5⬘ and 3⬘ ends of the insert and digested vector. We
constructed our vector and randomized insert with these homologous regions by
the use of long primers according to the manufacturer’s protocol.
To create the vector for use in the In-Fusion reaction, the pSCR2AleI⌬(3962030) plasmid was digested with AleI and XhoI and purified by agarose gel
electrophoresis, followed by gel extraction (5PRIME) prior to combining with
the randomized insert.
To construct the randomized insert, a PCR product (nt 369 to 2050) was
generated, using a mutagenic sense primer (sPal-random-5; Table 1) with degenerate nucleotides at positions 392 to 396 and an antisense primer
(asROD2050; Table 1) and using pSCR2 as a template. The PCR mixture
contained 0.4 ng of pSCR2, 0.2 M concentrations of the sense and antisense
primers, a 0.2 mM deoxynucleoside triphosphate mix, 1⫻ Taq standard buffer,
and 0.5 l of Taq polymerase enzyme (New England Biolabs) in a final reaction
volume of 50 l. A 40-cycle PCR protocol with a 55°C annealing temperature was

used. The PCR product (randomized insert) was purified by agarose gel electrophoresis.
The randomized insert was combined with the digested pSCR2AleI⌬(3962030) vector at a 2:1 ratio and transferred to an In-Fusion reaction tube. The
resulting recombined product was transformed into E. coli DH5␣, and DNA was
extracted from bulk transformation reactions to obtain the randomized proviral
DNA library. The degeneracy of pal region in the plasmids of this library was
checked by sequencing (see Table S1 in the supplemental material). Although
there was a bias in oligonucleotide synthesis that favored the incorporation of
purine samples somewhat over pyrimidines, each nucleotide was sufficiently
represented to ensure adequate mutagenesis at each position in the reconstructed proviral DNA library.
Cell culture and transfections of 5-nt RND pal library. COS-7 cells were
maintained in Dulbecco modified Eagle medium supplemented with 10% fetal
calf serum, penicillin, and streptomycin (Invitrogen). COS-7 cells were transfected with randomized library (5-nt RND pal plasmids) by using a Trans-ITCOS transfection kit (Mirus). At 2 days posttransfection, the cells and media
were harvested, and the presence of virus in the medium was monitored by using
a p27-specific enzyme-linked immunosorbent assay (ELISA; SIV p27 ELISA;
Zeptometrix).
Cell culture and infections of RND viruses. C8166 cells (NIH AIDS reagent
404) were maintained in RPMI 1640 medium supplemented with 10% fetal calf
serum, penicillin, streptomycin, and glutamine (Invitrogen). The media of transfected cells containing 5-nt pal viruses was filtered through 0.22-m-pore-size
filters. Viruses were collected from the media by centrifugation for 2 h at 4°C and
at 8,500 rpm (10,015 relative centrifugal force [RCF]). The resulting viral pellet
was resuspended in 2.0 ml of RPMI 1640. Subsequently, 1.5 ml was used for
infection in 105 C8166 cells. This 1.5 ml corresponded to 250 ng of HIV-2 CAp27
for 5-nt RND pal viruses, as determined by ELISA. An aliquot of 0.5 ml was
saved at ⫺80°C for RNA extraction. After 12 h at 37°C, cells were washed and
resuspended in fresh RPMI medium-fetal calf serum. Every 7 to 10 days, the
viruses produced in the media were filtered through 0.22-m-pore-size syringe
filters and used to reinfect 105 fresh uninfected C8166 cells.
Virus propagation for the 5-nt RND pal library was monitored by quantifying
the concentration of CAp27 protein (determined by ELISA; Zeptometrix) in the
medium at different days postinfection (data not shown). In addition, aliquots of
medium containing filtered viruses were saved at 4, 9, 15, and 41 days postinfection (dpi) for RNA isolation and analysis.
RNA isolation and analysis of nonselected and selected sequences from the
5-nt RND pal library. The total COS-7 intracellular vRNA and fractions of
COS-7 and C8166 (19 and 41 dpi) extracellular vRNAs from 5-nt RND pal
viruses were purified, using a Stratagene Absolutely RNA microprep kit. To
pellet the virus particles, saved aliquots were centrifuged for 2 h at 4°C and
15,000 rpm (21,882 RCF). Purified RNAs were used for RT-PCR (AccuScript
High-Fidelity RT-PCR system; Stratagene) using sBamT7R and asEco561 prim-
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Generation and selection of 5-nt RND pal library. We previously showed that the pal sequence (5⬘-GGAGUGCUCC3⬘), located at the 3⬘ end of ⌿, was important for regulating
SL1-mediated HIV-2 RNA dimerization in vitro (25). Using
SELEX methodology, we showed that this regulation is mediated by the formation of an extended SL1 structure created by
the interaction of the 3⬘ side of pal (GCUCC-3⬘) with an
immediate downstream sequence of SL1 (3). Moreover, formation of the extended SL1 structure is necessary during viral
replication (26). Although both studies demonstrated the importance of the 3⬘ side of pal, the role of the 5⬘ side of pal
(5⬘-GGAGU) was not well understood. Therefore, we investigated the role of 5⬘ side of pal in HIV-2 replication by subjecting this region to randomization and subsequent in vivo
selection.
The in vivo SELEX method starts with the generation of a
pool of viral genomes containing many possible mutations at
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ers (Table 1). An aliquot of each RT-PCR was sequenced directly as a pool,
while the rest of the reaction was digested with BamHI/EcoRI to clone individual
sequences. The digested products were ligated with the BamHI and EcoRI sites
of pUC18 vector and transformed in competent DH5␣ E. coli. Individual DNA
plasmids were sequenced to examine the in vivo selection of the viable sequences
and for further characterization.
Construction of individual plasmids with winner and loser sequences in the 5ⴕ
pal region. To construct full-length plasmids with the selected and nonselected
sequences in the 5⬘ pal region, we used the In-Fusion strategy described above
with the same vector but with different inserts that contained the desired mutations in the 5⬘ pal region. The inserts with nonselected “loser” (SM2 and TTB16) and selected “winner” (TTB-78) sequences were constructed, using sense
primers (sPal-SM2, sPal-TTB-16, and sPal-random-2, respectively) and the antisense primer asROD2050 in separate PCRs. Since the wild-type sequence was
one of the selected sequences (TTB-61 and TTB-76, see Table 3), we used the
modified pROD10 plasmid (26).
Transfections of nonselected and selected individual plasmids. Full-length
plasmids with loser and winner sequences were transfected in COS-7 cells individually as described above.
Replication assay of nonselected and selected clones. A total of 200 l of
medium from transfected COS-7 cells containing 0.6 ng of HIV-2 p27 capsid
protein, as determined by ELISA, was used to infect 105 C8166 cells. After 12 h,
cells were washed twice and resuspended in fresh RPMI medium-fetal calf
serum. Viral replication was monitored for up to 16 days for the selected and
nonselected individuals by quantifying the concentration of CAp27 protein (determined by ELISA; Zeptometrix) in the medium at different days postinfection.
Single-round infectivity assay of nonselected and selected individuals. The
infectivity of viruses in the medium of COS-7 cells was quantified by using
CMMT–CD4–LTR–␤-Gal indicator cells. This cell line expresses the CD4 receptor and contains a ␤-galactosidase gene fused to the HIV LTR, thus detecting
synthesis of the transactivating (Tat) protein after productive infection of the
cells by the input virus (9). After 2 days of culture postinfection, the cells were
stained for ␤-galactosidase activity, and the blue infected cells were counted. The
numbers were normalized first to the amounts of input viruses, as determined by
ELISA, and second to the level of infection by wild-type virus to give the
infectivities of viruses relative to the wild type.
RNA isolation and RNase protection assay for nonselected and selected individuals. The COS-7 intracellular vRNAs were purified by using a Stratagene
Absolutely RNA miniprep kit. For extracellular vRNAs, a fraction (1 ml) of the
medium was centrifuged for 2 h at 4°C and 15,000 rpm (21,882 RCF) to pellet the
viral particles, followed by lysis and RNA purification. Purified RNAs were used
separately for RNase protection assays (RPA III; Ambion), as described by the
manufacturer. The RNase protection assay was carried out using a 32P-labeled
antisense RNA probe complementary to positions 401 to 562 of the HIV-2 RNA
ROD isolate as described in reference 26). The antisense region was cloned into
the Promega pGEM 7Zf(⫹) vector (Novagen) so that the T7 transcript had
approximately 45 nucleotides of vector at its 5⬘ end. The non-HIV-2 tail of the
probe was used as a marker of the RNase digestion efficiency during the experiment.

––
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FIG. 1. Schematic of the 5⬘ untranslated leader region of HIV-2
genomic RNA. (A) The 5⬘ leader region of HIV-2 RNA is represented
with boxes and numbers to indicate the landmark sequences with their
names indicated above. TAR, poly(A) signal, PBS, , SL1, SD, and gag
represent the transactivation region, the poly (A) signal domain, the
primer binding site, the packaging signal, the stem-loop 1, the major
splice donor site, and the 5⬘ end of the Gag protein coding region,
respectively. (B) The secondary structure of ⌿-SL1 region (nt 380 to
448) (3, 15, 35). The pal element is a 10-nt palindrome sequence (nt
392 to 401) within ⌿, located immediately upstream of SL1 and is
represented by boldface letters. nt 392 to 396 and 397 to 401 represent
the 5⬘ and 3⬘ sides of pal, respectively. The 3⬘ pal sequence is involved
in a base-pairing interaction with a sequence downstream of SL1 and
creates stem B. The 5⬘ side of pal is a purine-rich motif upstream of 3⬘
pal pyrimidine-rich sequence. The 6-nt autocomplementary sequence
essential for SL1-mediated dimerization in the apical loop of SL1 is
outlined. (C) Five nucleotides at the 5⬘ side of pal (positions 392 to
396) were randomized in the insertion segment and inserted into the
full-length proviral DNA as described in the text. The last 5 nt of pal
(nt 397 to 401) were kept wild type so as not to disrupt stem B.

randomized sequences in a particular region (4). We synthesized a pool of HIV-2 proviral DNA genomes with five randomized nucleotides of pal at positions 392 to 396 so that the
DNA library harbored 392NNNNN396 sequence (where N has
an equal probability of being A, C, G, or T; Fig. 1C).
The recombinagenic method used for the generation of the
5-nt RND pal library is detailed in Materials and Methods.
Briefly, a pSCR2AleI⌬(396-2030) vector and an insert (randomized at 5⬘ pal) were assembled in an In-Fusion (Clontech)
recombinagenic reaction by virtue of the engineered homologous regions at their 5⬘ and 3⬘ ends. The recombined product
was transformed in E. coli to produce a library of full-length
HIV-2 proviral DNA plasmids with up to 1,024 (i.e., 45) possible sequence variations at the 5⬘ side of pal. To verify the
degeneracy of the library, a fraction of the bacteria transformed with the recombinagenic PCR products were counted
and their plasmids sequenced. Sequencing of 38 individual
clones (see Table S1 in the supplemental material) revealed
the presence of all four nucleotides at each position, although
some purine bias in the synthesized oligonucleotides was
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noted. The diversity of the library allowed adequate interrogation of each position in the 392-396 pal region.
To initiate selection, the purified plasmid DNA library was
first transfected into COS-7 cells to produce the library of 5-nt
RND pal viruses. To monitor the sequence diversity and to
confirm that no individual sequence was dominating in the 5-nt
RND pal library at the transfection stage, we analyzed the
leader sequences of intracellular and packaged genomic RNAs
after RT-PCR. Sequence analysis of the RT-PCR product as a
pool showed that COS-7 intracellular and packaged vRNAs
contained random sequences at the 5⬘ side of pal (data not
shown). In addition, RT-PCR products were subcloned to obtain the sequence of individual clones. Sequence analysis of 25
and 21 individual clones from COS-7 intracellular and packaged (extracellular) vRNAs, respectively, confirmed that no
single sequence was predominating in the library at this stage
(Table 2). However, a bias toward purine samples at nt 392 to
396 was already evident in the viral RNAs that were packaged
and exported as viral particles into the media of the transfected
COS-7 cells.
To study the selection of 5⬘ pal sequences during viral replication and infection cycles, media from COS-7 transfected
cells were used to infect permissive C8166 cells. Virus production was detected within a few days of infection in the media of
C8166 cells by p27 capsid ELISA. Therefore, we harvested
virus at 4 dpi, followed by vRNA purification, RT-PCR, and
sequencing. Sequence analysis of the RT-PCR products
showed selection at 4 dpi for G’s at positions 392 and 393 (data
not shown). Sequencing viral RNA from 9 and 15 dpi showed
that the selection was complete at position 392 and nearly
complete for positions 393 and 395 (Table 3). By 41 dpi, selection was obvious for the entire RND region: viral RNAs had
converged on the consensus sequence GGRGN (Table 3),
where N represents T, G, or A at position 396 (no C’s were
observed). The absence of C396 in the recovered viral RNAs
may have been a result of negative selection, a sampling artifact, or because of the relative underrepresentation of C in the
library. C396 viruses were present as packageable viruses in the
posttransfection sampling, so it appears that they are viable but
are likely overrun during longer infection schemes (Table 2).
A purine-rich sequence on the 5ⴕ side of pal is important for
viral replication. In wild-type HIV-2 the 5⬘ side of pal contains
a purine-rich sequence (5⬘-GGAGU) and the in vivo 5-nt
RND pal selection demonstrated the importance of the 5⬘GGRGN motif. We therefore compared the viral replication
properties of pyrimidine-rich nonconsensus and purine-rich
consensus clonal viruses. The pyrimidine-rich clones used in
this experiment were TTB-16, a nonsurviving intracellular
COS-7 sequence (5⬘-accug, where lowercase letters signify nucleotides different from the wild-type sequence; Table 2), and
SM2 (5⬘-cuccU; Fig. 2), a replication-deficient 5⬘ pal pyrimidine-rich mutant previously described by Lever and coworkers
(30). The winner viruses were the purine-rich clones TTB-76
(5⬘-GGAGU [wild-type sequence]; Table 3) and TTB-78
(GGgGU; Table 3).
Duplicate samples of these four DNA constructs were transfected into COS-7 cells. At 48 h after transfection, viruses were
harvested and used to infect C8166 cells with an equivalent
amount of p27 capsid, as measured by ELISA. Virus spread
was followed by measuring p27 capsid in the C8166 media by
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TABLE 2. Sequence of 5-nt RND pal virus library inside and
outside of COS-7 cells after transfectiona
Nucleotide at position:

Category and clone
no.

392

393

394

395

396

Intracellular vRNA
Wild type
TTB-1
TTB-2
TTB-3
TTB-4
TTB-5
TTB-6
TTB-7
TTB-8
TTB-9
TTB-10
TTB-11
TTB-12
TTB-13
TTB-14
TTB-15
TTB-16
TTB-17
TTB-18
TTB-19
TTB-20
TTB-21
TTB-22
TTB-23
TTB-24
TTB-25

G
A
A
U
A
G
C
G
A
A
A
A
A
U
G
U
A
U
G
G
A
G
A
A
U
G

G
G
A
C
G
G
A
G
U
A
A
G
G
A
G
A
C
U
U
U
A
G
C
C
A
G

A
C
U
U
G
G
G
C
G
G
A
G
A
A
C
G
C
A
G
U
G
C
G
U
C
A

G
U
U
A
A
A
G
C
C
U
A
A
A
C
A
G
U
G
G
U
G
A
G
G
A
A

U
U
U
A
A
G
G
G
U
C
A
A
C
G
G
U
G
U
C
U
C
G
G
G
G
G

Extracellular vRNA
Wild type
TTB-26
TTB-27
TTB-28
TTB-29
TTB-30
TTB-31
TTB-32
TTB-33
TTB-34
TTB-35
TTB-36
TTB-37
TTB-38
TTB-39
TTB-40
TTB-41
TTB-42
TTB-43
TTB-44
TTB-45
TTB-46

G
G
A
G
A
G
C
A
G
U
G
G
G
A
A
G
G
G
G
G
G
A

G
U
G
G
A
U
A
A
G
U
G
A
G
G
G
U
C
G
G
G
G
U

A
G
A
A
G
A
U
G
G
A
G
A
G
A
G
A
U
G
C
A
G
G

G
A
A
A
G
A
A
G
G
A
U
G
U
G
A
G
U
G
U
A
U
C

U
G
C
A
G
G
G
A
G
C
A
U
U
G
U
G
U
C
G
A
G
G

a
vRNAs extracted from COS-7 cells (intracellular) and media (extracellular) were
subjected to RT-PCR, cloning, and sequencing as described in Materials and Methods.
TTB-1 to TTB-25 represent RNAs that were expressed intracellularly and may or may
not be packageable. TTB-26 to TTB-46 represent vRNAs that were exported as viral
particles into the media of COS-7 cells and thus were at least marginally competent for
packaging. TTB-16 was tested for infectivity and packaging.

ELISA. Infections with purine-rich TTB-76 and TTB-78 viruses led to robust virus production, whereas those with pyrimidine-rich SM2 and TTB-16 sequences showed low or no virus
production for up to 16 dpi (Fig. 2). These results support our
hypothesis that the purine-rich 5⬘-GGRGN in the 5⬘ side of pal
is essential for viral replication.
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TABLE 3. S⬘ Pal sequences of viruses that were selected after
several rounds of infection in C8166 cellsa
Nucleotide at position:

Time postinfection
and clone no.

392

393

394

395

396

9 dpi
Wild type
TTB-47/48
TTB-49/50
TTB-51/52
TTB-53/54
TTB-55
TTB-56
TTB-57/58
TTB-59
TTB-60
TTB-61
TTB-62/65

G
G
G
G
G
G
G
G
G
G
G
G

G
G
G
G
G
G
G
G
G
G
G
A

A
A
A
G
A
G
G
G
U
U
A
G

G
A
G
G
G
U
C
C
A
A
G
G

U
A
G
G
A
A
G
A
G
A
U
G

41 dpi
Wild type
TTB-66/71
TTB-72/75
TTB-76
TTB-77
TTB-78/80
TTB-81
TTB-82

G
G
G
G
G
G
G
G

G
G
G
G
G
G
G
G

A
A
A
A
A
G
G
G

G
G
G
G
A
G
U
U

U
A
G
U
G
U
A
G

a
vRNAs extracted from viruses at 9 and 41 dpi were subjected to RT-PCR and
cloning as described in Materials and Methods. TTB-47 to TTB-65 (9 dpi) and
TTB-66 to TTB-82 (41 dpi) clones were sequenced in the 5⬘ pal region. Sequences that appeared two or more times are shown in only one row (e.g.,
TTB-66/71 for TTB-66 to TTB-71). The individual clones TTB-76 (wild type)
and TTB-78 were tested for infectivity and packaging.

Purine-rich sequence (GGRGN) on the 5ⴕ side of pal is
important for genomic RNA packaging. To further identify
which steps of HIV-2 viral replication in C8166 cells were
affected by non-wild-type substitutions in the 5⬘ side of pal,
viruses produced from transfection of COS-7 cells with SM2,
TTB-16, TTB-76 (wild type), and TTB-78 proviral DNAs were
assessed for infectivity and/or entry in CMMT–CD4–LTR–␤Gal indicator cells. The infectivity of these cells can be examined by the detection of a Tat-driven reporter gene, whose
expression is dependent on HIV entry into the cell (9). As
observed in C8166 cells, SM2 and TTB-16 also showed a lower
level of infectivity in CMMT–CD4–LTR–␤-Gal indicator cells
compared to TTB-76 and TTB-78 (Fig. 3A).
Since the packaging signals in retroviruses contain purinerich motifs (5) and the 5⬘ pal element is both purine-rich and
located within the HIV-2 packaging signal (21, 26), we investigated the role of 5⬘ side of pal as an important RNA packaging element. We assessed and compared the packaging of
RNAs containing consensus 5⬘ pal sequence (TTB-76 [wild
type] and TTB-78) with packaging of RNAs containing the
nonconsensus 5⬘ pal sequence (TTB-16 and SM2). We performed RNase protection assays (Fig. 3) on TTB-16, SM2,
TTB-76 (wild type), and TTB-78 RNAs extracted from the
cytoplasm of COS-7 transfected cells and from the COS-7produced viruses. As seen in Fig. 3, none of the sequences
affected the level of genomic RNA in the cytoplasm of the
transfected cells relative to the wild type. However, virions
produced by these transfected cells showed that the level of
genomic RNA packaging was high in the consensus 5-nt RND

pal viruses (TTB-76 and TTB-78) but was reduced in the pyrimidine-rich 5⬘ pal viruses (TTB-16 and SM2) (10 to 15%)
compared the wild type (Fig. 3C). Further, to ensure that
mutations in 5⬘ side of pal did not affect viral gene expression,
we analyzed viral proteins from intra- and extracellular COS-7
fractions by Western blot analysis. Our data show that mutation of 5⬘ pal region does not affect viral gene expression (Fig.
4). These data taken together suggest that the replication defect seen in viruses with a pyrimidine-rich 5⬘ pal sequence is
due to a packaging defect.
DISCUSSION
Retroviral packaging occurs by means of interactions between the nucleocapsid (NC) domain of the Gag polyprotein
and the packaging signal (⌿) of unspliced genomic RNA (for
a review, see reference (17). For HIV-2, ⌿ is located upstream
of the major splice donor site, SD, in the 5⬘ untranslated leader
region of genomic RNA (Fig. 1). In the present study, we
investigated the role of pal, a 10-nt palindrome sequence (5⬘392GGAGUGCUCC401) situated within ⌿ (Fig. 1). The 3⬘ side
of pal (GCUCC-3⬘) contributes to the formation of stem B, an
extension of SL1 involved in the packaging of HIV-2 RNA,
although the function of the 5⬘ side of pal (5⬘-GGAGU) was
less well defined (26). To ascertain the sequence constraints
and role(s) of pal, we used a randomization/in vivo selection

TTB-78
TTB-16
SM2

G G g GU
a cc ug
c cu cU
392

396

800
600
400
200
0

0

3

6

9

12

15

FIG. 2. Mutant HIV-2 viruses harboring pyrimidines at the 5⬘ side
of pal exhibit replication defects. (Top) Sequence at the 5⬘ side of pal
(nt 392 to 396) in wild-type and mutant individuals used in this experiment. TTB-76 (wild type) and TTB-78 contain the pal sequence derived from viral clones that were winners after extended serial passage
(Table 3). TTB-16 represents a sequence that was observed intracellularly after transfection but that did not survive during serial infections in C8166 cells (Table 2). SM2 is a packaging-deficient mutant
previously characterized by the Lever group that was used here for
comparison with our own clones containing pyrimidines in the 5⬘ side
of pal (30). The mutated residues are represented by lowercase letters.
(Bottom) Replication kinetics of wild-type (f), TTB-78 (䡺), TTB-16
(E), and SM2 (‚) viruses in C8166 cells. Equal amounts of viral
particles (0.6 ng of p27 capsid, as determined by ELISA), produced in
the media by transfection of DNA plasmids in COS-7 cells, were used
to infect permissive C8166 cells. Virus production from these cells was
assayed for the production of p27 capsid at various intervals postinfection. The results are based on infections of separate plates of permissive cells using virus harvested from two independent transfections
for each clone. Error bars represent one standard deviation for a
representative experiment.
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FIG. 4. Mutations within the 5⬘ side of pal do not affect viral gene
expression. (A) Western blot analysis of COS-7 extracellular viral
proteins. Protein samples from equivalent number of virions, as determined by p27 capsid ELISA, were loaded into each lane. HIV-2 proteins were detected with human serum from an HIV-2-infected patient. Lanes 1, 2, 3, and 4 represent proteins from the TTB-76 (wild
type) (5⬘-GGAGU), SM2 (5⬘-ccucU) (30), TTB-16 (5⬘-accug), and
TTB-78 (5⬘-GGgGU) viruses, respectively. (B) Western blot analysis
of COS-7 intracellular viral proteins. Wild-type and 5⬘ pal mutants
were tested for viral gene expression inside the COS-7 cells. An equal
amount of cell lysate was loaded into each lane. HIV-2 proteins were
detected with human serum from an HIV-2-infected patient (HIV-2
reference sera, NIH AIDS Research and Reference Reagent Program
7G 1337 and 6F D150). Lanes 1, 2, 3, and 4 represent proteins from
COS-7 cells transfected with TTB-76 (wild type) (5⬘-GGAGU) and the
5⬘ pal mutants (SM2 (5⬘-ccucU) (30), TTB-16 (5⬘-accug), and TTB-78
(5⬘-GGgGU), respectively. The positions of the detected proteins with
their molecular sizes are shown.

FIG. 3. HIV-2 virus infectivity and genomic RNA packaging are
decreased by the presence of pyrimidines at the 5⬘ side of pal. (A) Single-round infectivity assay for wild-type and 5⬘ pal mutant viruses
isolated from transfected COS-7 cells using CMMT–CD4–LTR–␤-Gal
indicator cells (see Materials and Methods). Sequences of wild-type
and mutant 5⬘ pal for the viruses used in this experiment are shown at
the top panel of Fig. 2. Virus generated by transfection of COS-7 cells
was quantified by p27 ELISA and used to infect the indicator cells. At
48 h postinfection, cells were stained to visualize cellular ␤-Gal expression. Infectivity was normalized to the infectivity of the wild-type
virus, set at 100%. Infectivity was measured in two independent experiments, and results are shown with error bars that represent the
standard deviation. (B) Quantification of full-length genomic RNA in
the cytoplasmic fraction of COS-7 cells transfected with wild-type and
5⬘ pal mutants using an RNase protection assay. Cells were harvested
from two independent transfections of wild-type and 5⬘ pal mutants. A
3-g portion of cytoplasmic RNA was probed with 2 ⫻ 106 cpm of
labeled riboprobe. Lanes 1, 2, 3, and 4 represent amounts of genomic
RNAs from TTB-76 (wild type) (5⬘-GGAGU), SM2 (5⬘-ccucU) (30),
TTB-16 (5⬘-accug), and TTB-78 (5⬘-GGgGU) viruses, respectively.
Lanes 5 represents yeast RNA used as a nonspecific target RNA
control, incubated without RNases. (C) Quantification of full-length
genomic RNA in wild-type and 5⬘ pal mutant viruses using an RNase
protection assay. Viruses were harvested from the media of transfected
COS-7 cells from two independent transfections of wild-type and 5⬘ pal
mutants. First, the extracted RNAs from these viruses were normalized
to the amount of viral particles (p27 capsid as determined by ELISA),
and an equivalent amount of these RNAs was probed with 5 ⫻ 105 cpm
of labeled riboprobe. Lanes 1, 2, 3, and 4 represent amounts of

methodology to investigate the sequences in pal that are important for packaging and replication. In vivo selection approaches have been used previously to isolate replication-competent viruses from a complex population of viruses during
replication in eukaryotic cells (4, 16, 37). This method allows
for mutational analysis of an ensemble of variant viruses without making a priori assumptions that might influence the
choice of mutations. In contrast to the methods used before,
we used a recombinagenic method that enables high-efficiency
incorporation of the randomized region into the proviral DNA
vector. We were able to select from among a large number of
mutant viral sequences only those that were viable.
After in vivo selection of the RND pal viral libraries, sequence analysis showed that nucleotide variation was not well
tolerated at positions 392, 393, and 395 of the 5⬘ pal region
during viral replication, and G was strongly selected at each of
these positions. For position 394, the dominance of A among
the viable winner viruses also reflects its importance for viral
replication. This finding is supported by phylogenetic analysis
(Fig. 5B) and our previous phenotypic reversion study in which
mutant pal viruses harboring an A394G substitution reverted
back to A (26). Here, in the 5-nt RND pal selection, a consensus sequence (5⬘-GGRG) emerged in all viruses surviving
the competition after several passages. We interpret this to
mean that the 5⬘-GGRG sequence is essential for optimal
HIV-2 replication. In support of this, two nonselected loser

genomic RNAs from COS-7 cells transfected with TTB-76 (wild type)
(5⬘-GGAGU) and the 5⬘ pal mutants (SM2 (5⬘-ccucU) (30), TTB-16
(5⬘-accug), and TTB-78 (5⬘-GGgGU), respectively. Lanes 5 and 6
represent yeast RNA used as a nonspecific target RNA control, incubated with or without RNases, respectively. (D) Schematic representation of the radioactive probe used in this experiment and a predicted
protected fragment corresponding to the unspliced leader region. wt,
wild type.
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FIG. 5. Predicted secondary structures of selected (winner) and nonselected (loser) RNAs. (A) Secondary structure model of pal-SL1 domain
in HIV-2 ROD isolate (GenBank accession no. M15390) (3, 26) as predicted by Mfold (44). Stem B represents the interaction between the
5⬘-GCUCC of pal and the GGAGC-3⬘ sequence just downstream of SL1. (B and C) Stem B structure in HIV-2/SIV strains (28) and in the selected
(winner) sequences derived from serial passage of the 5-nt RND library is indicated. The stem B structure was predicted using two-state
hybridization model on the DINAMelt server (http://www.bioinfo.rpi.edu/applications/hybrid/twostate.php) using standard parameters (RNA at
37°C, [Na⫹] ⫽ 1 M, [Mg2⫹] ⫽ 0 M, and [strand] ⫽ 0.00001 M) (33). The consensus purine-rich motif and the proportion of bases at position 396
in HIV-2/SIV strains and the winner viruses is shown to the left. (D and E) The GGAG sequence at 3⬘ end of stem B in TTB-16 and SM2 is
sequestered by base pairing with pyrimidines at the 5⬘ end of pal and potentially makes stem B significantly more stable. The nucleotides different
from the wild-type sequence are shown with lowercase letters.

viruses with nonconsensus pyrimidine-rich sequences were deficient in infectivity and replication (Fig. 2 and 3).
Compared to the strong selective pressure seen for positions
392 to 395, there were no obvious sequence constraints at
position 396, except that we did not observe any C’s at this
position in the final pool. The lack of C’s at 396 may indicate
that viruses with C396 are somewhat impaired and are successfully outcompeted in this assay, or it may reflect a sampling
artifact, since we have observed in previous studies that mutant
viruses harboring A or C at position 396 replicated like the wild
type during short-time-course infections (J.-M. Lanchy, unpublished data). It should be noted that position 396 exhibits a
lower degree of phylogenetic conservation than adjacent residues among HIV-2/SIV isolates (28).
On the basis of previous studies (26, 30) and the present
work, we propose that the 5⬘ pal region comprises an essential
component of the core packaging signal of HIV-2 RNA. First,
as described above, winning viruses derived from the in vivo
selection shared a consensus 5⬘-GGRG sequence (Table 3).
Second, this region is highly conserved among different strains
of HIV-2 and SIV, where 37 of 37 published sequences show
the 5⬘-GGAG sequence at this location (Fig. 5) (28). Third,
packaging was strongly diminished in mutant viruses harboring
sequences other than the 5⬘-GGRG sequence (Fig. 3C) (30).
Several studies have demonstrated that the interaction between RNA and the packaging proteins Gag/NC is enhanced
by the presence of unpaired G residues in the target RNA (13,
39, 43). In the present study, secondary structure predictions of
winner sequences suggest that, like that of the wild type, the
5⬘-GGRG sequence is unpaired (compare Fig. 5A and C),
while among the loser viruses the 5⬘ side of pal was predicted
to engage in stable base pairing with sequences downstream of
SL1 (Fig. 5D and E). Because of the similarities with known

Gag/NC binding preferences (13, 19, 26, 30, 39), the 5⬘-GGRG
consensus is likely to be an essential element for Gag/NC
recognition and binding.
In addition to its probable importance for Gag/NC binding,
the ⌿-SL1 region of HIV-2 RNA adopts a specific conformation (at least transiently) during replication that is essential for
efficient packaging. This conformation involves base pairing
between the 3⬘ side of pal and the sequence downstream of
SL1 that results in the formation of stem B (Fig. 1B and 5A).
Mutations disrupting stem B negatively affect RNA packaging
(21, 26, 35). Our present selection and RNA folding results
raise the possibility that RNAs of TTB-16 and SM2 were packaging deficient due to the increased stability of extended SL1.
The ⌬G values for TTB-16 and SM2 SL1 RNA structures were
⫺9.9 and ⫺11.7 kcal/mol, respectively, while wild-type and
winner RNA sequences folded with a predicted ⌬G value of
⫺8.3 kcal/mol. Hyperstabilization of stem B may lead to a less
favorable interaction of NC with this region (23) or to the
sequestration of normally unpaired G residues that may be
critical NC binding determinants (13, 19, 39).
Analysis of the predicted extended SL1 structures highlighted the presence of additional conserved 5⬘-GGAG sequences located downstream of stem B. In particular, packaging models presented by Summers and coworkers suggest that
Gag/NC binds poorly to RNAs in which NC-binding elements
are sequestered by base-pairing interactions with other regions
(14, 18). We suggest that the downstream 5⬘-GGAG sequence(s) could be a target for NC binding and cooperate with
the 5⬘ GGRG motif to mediate packaging of HIV-2 RNA. This
might explain why TTB-16 and SM2, in which the second
5⬘-GGAG was sequestered in an extended stem B (Fig. 5D and
E), were packaging impaired (Fig. 3C).
On a technical note, we found that the use of the recombi-
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nagenic method provided a more efficient route to generate
the randomized proviral DNA than traditional ligation protocols. In vivo selection has been used to characterize important
viral RNA signals previously, but difficulty in generating the
library of randomized proviral DNA limited the number of
sequences that could be simultaneously examined (4, 16; T. T.
Baig and J.-M. Lanchy, unpublished data). This enhanced synthesis of randomized proviral DNA allows a larger degenerate
segment to be tested.
A growing body of evidence points to the importance of the
pal element within the HIV-2 core packaging signal (21, 26, 30,
35). The palindromic nature of this element has been enigmatic, but the present study demonstrates that pal is really
composed of two complementary motifs, one that is required
to be single stranded and a likely target for protein recognition,
and the other that is crucial for an RNA-RNA interaction to
form stem B. Because the major packaging signal (⌿) in HIV-2
RNA is located upstream of SD and is thus present in both
spliced and unspliced RNA species (Fig. 1), it is remarkable
that only unspliced RNA is packaged. To gain further insights
into the mechanism of HIV-2 packaging and RNA selectivity,
it will be interesting to investigate the binding affinities of
packaging proteins Gag/NC for spliced and unspliced RNA
constructs. These experiments are under way in our laboratory.
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